Belgium Infectious Respiratory Disease Diagnostics Market Size & Outlook

The infectious respiratory disease diagnostics market in Belgium is expected to reach a projected revenue of US$ 84.9 million by 2033. A compound annual growth rate of 2.5% is expected of Belgium infectious respiratory disease diagnostics market from 2025 to 2033.
Revenue, 2024 (US$M)
$68.1
Forecast, 2033 (US$M)
$84.9
CAGR, 2025 - 2033
2.5%
Report Coverage
Belgium

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Belgium infectious respiratory disease diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Belgium infectious respiratory disease diagnostics market highlights

  • The Belgium infectious respiratory disease diagnostics market generated a revenue of USD 68.1 million in 2024 and is expected to reach USD 84.9 million by 2033.
  • The Belgium market is expected to grow at a CAGR of 2.5% from 2025 to 2033.
  • In terms of segment, reagents was the largest revenue generating product in 2024.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Infectious respiratory disease diagnostics market data book summary

Market revenue in 2024USD 68.1 million
Market revenue in 2033USD 84.9 million
Growth rate2.5% (CAGR from 2025 to 2033)
Largest segmentReagents
Fastest growing segmentReagents
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents, Services
Key market players worldwideAbbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche


Other key industry trends

  • In terms of revenue, Belgium accounted for 0.6% of the global infectious respiratory disease diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 519.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Respiratory Disease Diagnostics Market Companies

Name Profile # Employees HQ Website
Roche View profile 10001+ Basel, Basel-Stadt, Switzerland, Europe http://www.roche.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Koninklijke Philips NV View profile 73712 Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC https://www.philips.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Belgium infectious respiratory disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 66.67% in 2024. Horizon Databook has segmented the Belgium infectious respiratory disease diagnostics market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Belgium infectious respiratory disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Belgium infectious respiratory disease diagnostics market databook

  • Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Belgium infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Belgium infectious respiratory disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Belgium infectious respiratory disease diagnostics market size, by product, 2021-2033 (US$M)

Belgium Infectious Respiratory Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)

Belgium infectious respiratory disease diagnostics market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online